As of August 28, 2026, Syndax Pharmaceuticals, Inc. (SNDX) has a DilutionWatch DilutionScore of 28/100, rated MEDIUM dilution risk. Syndax Pharmaceuticals, Inc. has a market capitalization of $1.74B, 89.30M shares outstanding, 246 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 7%
🔁 Convertible Conversion
model 15%
• Convertible debt present: 14.1% potential dilution
Market Data
Market Cap$1.74B
Shares Outstanding89.30M
Float79.03M
Cash$547.86M
Debt$344.03M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 12.6% shares (2026Q1 vs prior)
246 institutional holders · 120.03M shares
#1
GOLDMAN SACHS GROUP INC
10.69M shares
#2
BlackRock, Inc.
8.25M shares
#3
Kynam Capital Management, LP
8.05M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest22.67M
Days to Cover18.6
% of Float28.7%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2026-06-30
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual SNDX Dilution Snapshot
Syndax Pharmaceuticals, Inc. (SNDX) has a DilutionScore of 28/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for SNDX: xbrl on 2026-06-30.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track SNDX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SNDX — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for SNDX
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.